| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery—Systematic review and meta‐analysis
|
Presume, João
|
|
|
20 |
12 |
p. 2930-2938
|
artikel
|
| 2 |
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
|
Deconinck, Shannen J.
|
|
|
20 |
12 |
p. 2797-2809
|
artikel
|
| 3 |
Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
|
van Osch, Thijs L.J.
|
|
|
20 |
12 |
p. 3011-3025
|
artikel
|
| 4 |
Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients
|
Favaloro, Emmanuel J.
|
|
|
20 |
12 |
p. 2896-2908
|
artikel
|
| 5 |
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
|
Potere, Nicola
|
|
|
20 |
12 |
p. 2964-2971
|
artikel
|
| 6 |
Bifunctional effect of the inflammatory cytokine tumor necrosis factor α on megakaryopoiesis and platelet production
|
Chu, Tiantian
|
|
|
20 |
12 |
p. 2998-3010
|
artikel
|
| 7 |
Bleeding after liver biopsy: Remarkably infrequent but potentially serious and unfortunately unpredictable by extensive clinical laboratory analyses—Take a closer look at the biopsy?
|
Caldwell, Stephen H.
|
|
|
20 |
12 |
p. 2756-2757
|
artikel
|
| 8 |
Citrullinated fibrinogen forms densely packed clots with decreased permeability
|
Varjú, Imre
|
|
|
20 |
12 |
p. 2862-2872
|
artikel
|
| 9 |
Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure
|
Shaw, Joseph R.
|
|
|
20 |
12 |
p. 2953-2963
|
artikel
|
| 10 |
Comparative sequence analysis of vitamin K‐dependent coagulation factors
|
Stojanovski, Bosko M.
|
|
|
20 |
12 |
p. 2837-2849
|
artikel
|
| 11 |
COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid
|
Moiseiwitsch, Nina
|
|
|
20 |
12 |
p. 2909-2920
|
artikel
|
| 12 |
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
|
Li, Na
|
|
|
20 |
12 |
p. 2988-2997
|
artikel
|
| 13 |
Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet‐induced obesity and associated pathologies
|
Hur, Woosuk S.
|
|
|
20 |
12 |
p. 2873-2886
|
artikel
|
| 14 |
Exclusively breastmilk‐fed preterm infants are at high risk of developing subclinical vitamin K deficiency despite intramuscular prophylaxis at birth
|
Clarke, Paul
|
|
|
20 |
12 |
p. 2773-2785
|
artikel
|
| 15 |
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies
|
Fauché, Alexandre
|
|
|
20 |
12 |
p. 2850-2861
|
artikel
|
| 16 |
Genetic risk and incident venous thromboembolism in middle‐aged and older adults following COVID‐19 vaccination
|
Xie, Junqing
|
|
|
20 |
12 |
p. 2887-2895
|
artikel
|
| 17 |
Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer
|
Moik, Florian
|
|
|
20 |
12 |
p. 2733-2745
|
artikel
|
| 18 |
How often are parenteral anticoagulants administered by parents?
|
Favaloro, Emmanuel J.
|
|
|
20 |
12 |
p. 2746-2750
|
artikel
|
| 19 |
Issue Information
|
|
|
|
20 |
12 |
p. i-v
|
artikel
|
| 20 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
20 |
12 |
p. 3039-3040
|
artikel
|
| 21 |
Keep minds opening for chronic thromboembolic pulmonary hypertension: More data, less clarity
|
Zhou, Yu‐Ping
|
|
|
20 |
12 |
p. 2751-2753
|
artikel
|
| 22 |
Klotho, a protective renal factor for platelet lifespan
|
Peng M.D., Jun
|
|
|
20 |
12 |
p. 2754-2755
|
artikel
|
| 23 |
Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study
|
Scully, Marie
|
|
|
20 |
12 |
p. 2810-2822
|
artikel
|
| 24 |
Mechanisms of ADAMTS13 regulation
|
DeYoung, Veronica
|
|
|
20 |
12 |
p. 2722-2732
|
artikel
|
| 25 |
Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH
|
Wang, Tzu‐Fei
|
|
|
20 |
12 |
p. 3026-3038
|
artikel
|
| 26 |
Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures
|
Bissonnette, Julien
|
|
|
20 |
12 |
p. 2786-2796
|
artikel
|
| 27 |
Protease‐ and cell type–specific activation of protease‐activated receptor 2 in cutaneous inflammation
|
Fleischer, Maria Isabel
|
|
|
20 |
12 |
p. 2823-2836
|
artikel
|
| 28 |
Renal Klotho safeguards platelet lifespan in advanced chronic kidney disease through restraining Bcl‐xL ubiquitination and degradation
|
Lan, Qigang
|
|
|
20 |
12 |
p. 2972-2987
|
artikel
|
| 29 |
Reproductive health and hemostatic issues in women and girls with congenital factor VII deficiency: A systematic review
|
Abdul-Kadir, Rezan
|
|
|
20 |
12 |
p. 2758-2772
|
artikel
|
| 30 |
The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
|
Smith, Christopher W.
|
|
|
20 |
12 |
p. 2939-2952
|
artikel
|
| 31 |
The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
|
Overvad, Thure F.
|
|
|
20 |
12 |
p. 2921-2929
|
artikel
|
| 32 |
What the neighbors say
|
|
|
|
20 |
12 |
p. 2721
|
artikel
|
Tijdschrift beschrijving